LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | GSK1904529A | 0.12 | uM | LJP6 | 2 | H23 | 72 | hr | 2543 | 4876 | 5438 | 0.8967 | 0.8107 |
| SK-BR-3 | GSK1904529A | 0.12 | uM | LJP6 | 3 | H23 | 72 | hr | 2543 | 4915 | 5557 | 0.8844 | 0.7936 |
| SK-BR-3 | GSK1904529A | 0.37 | uM | LJP6 | 1 | H22 | 72 | hr | 2543 | 5495 | 5258 | 1.0449 | 1.0856 |
| SK-BR-3 | GSK1904529A | 0.37 | uM | LJP6 | 2 | H22 | 72 | hr | 2543 | 5337 | 5438 | 0.9814 | 0.9660 |
| SK-BR-3 | GSK1904529A | 0.37 | uM | LJP6 | 3 | H22 | 72 | hr | 2543 | 5407 | 5557 | 0.9729 | 0.9519 |
| SK-BR-3 | GSK1904529A | 1.11 | uM | LJP6 | 1 | H21 | 72 | hr | 2543 | 5588 | 5258 | 1.0626 | 1.1193 |
| SK-BR-3 | GSK1904529A | 1.11 | uM | LJP6 | 2 | H21 | 72 | hr | 2543 | 5529 | 5438 | 1.0167 | 1.0305 |
| SK-BR-3 | GSK1904529A | 1.11 | uM | LJP6 | 3 | H21 | 72 | hr | 2543 | 5493 | 5557 | 0.9884 | 0.9795 |
| SK-BR-3 | GSK1904529A | 3.33 | uM | LJP6 | 1 | H20 | 72 | hr | 2543 | 5623 | 5258 | 1.0692 | 1.1319 |
| SK-BR-3 | GSK1904529A | 3.33 | uM | LJP6 | 2 | H20 | 72 | hr | 2543 | 5456 | 5438 | 1.0033 | 1.0060 |
| SK-BR-3 | GSK1904529A | 3.33 | uM | LJP6 | 3 | H20 | 72 | hr | 2543 | 5706 | 5557 | 1.0267 | 1.0474 |
| SK-BR-3 | GSK1904529A | 10 | uM | LJP6 | 1 | H19 | 72 | hr | 2543 | 5806 | 5258 | 1.1040 | 1.1981 |
| SK-BR-3 | GSK1904529A | 10 | uM | LJP6 | 2 | H19 | 72 | hr | 2543 | 5367 | 5438 | 0.9869 | 0.9761 |
| SK-BR-3 | GSK1904529A | 10 | uM | LJP6 | 3 | H19 | 72 | hr | 2543 | 5762 | 5557 | 1.0368 | 1.0652 |
| SK-BR-3 | Linsitinib | 0.04 | uM | LJP5 | 1 | O24 | 72 | hr | 2543 | 4461 | 5734 | 0.7779 | 0.6145 |
| SK-BR-3 | Linsitinib | 0.04 | uM | LJP5 | 2 | O24 | 72 | hr | 2543 | 4044 | 5761 | 0.7019 | 0.4816 |
| SK-BR-3 | Linsitinib | 0.04 | uM | LJP5 | 3 | O24 | 72 | hr | 2543 | 4530 | 5760 | 0.7863 | 0.6313 |
| SK-BR-3 | Linsitinib | 0.12 | uM | LJP5 | 1 | O23 | 72 | hr | 2543 | 4874 | 5734 | 0.8499 | 0.7411 |
| SK-BR-3 | Linsitinib | 0.12 | uM | LJP5 | 2 | O23 | 72 | hr | 2543 | 4761 | 5761 | 0.8264 | 0.7014 |
| SK-BR-3 | Linsitinib | 0.12 | uM | LJP5 | 3 | O23 | 72 | hr | 2543 | 5134 | 5760 | 0.8912 | 0.8139 |
| SK-BR-3 | Linsitinib | 0.37 | uM | LJP5 | 1 | O22 | 72 | hr | 2543 | 5190 | 5734 | 0.9051 | 0.8369 |
| SK-BR-3 | Linsitinib | 0.37 | uM | LJP5 | 2 | O22 | 72 | hr | 2543 | 5085 | 5761 | 0.8826 | 0.7991 |
| SK-BR-3 | Linsitinib | 0.37 | uM | LJP5 | 3 | O22 | 72 | hr | 2543 | 5489 | 5760 | 0.9528 | 0.9197 |
| SK-BR-3 | Linsitinib | 1.11 | uM | LJP5 | 1 | O21 | 72 | hr | 2543 | 4921 | 5734 | 0.8581 | 0.7554 |
| SK-BR-3 | Linsitinib | 1.11 | uM | LJP5 | 2 | O21 | 72 | hr | 2543 | 4828 | 5761 | 0.8380 | 0.7217 |